Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06338241
Other study ID # CPP2021-008391
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date March 2, 2024
Est. completion date September 2, 2025

Study information

Verified date April 2024
Source University of Santiago de Compostela
Contact MARIO PEREZ SAYANS GARCIA, PHD, PHD
Phone +34626233504
Email mario.perez@usc.es
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The clinical study aims to assess the osteogenic effects of Galibone+ in bone regeneration post-extraction of impacted mandibular third molars.


Description:

With a focus on both clinical and radiological outcomes, the study seeks to compare the efficacy of Galibone+ against a standard material (Bio-Oss) through a double-blind, randomized split-mouth trial involving 30 patients. Variables including pain, inflammation, and post-surgical complications will be monitored during the initial seven-day follow-up, while bone volume reduction and mineral density will be evaluated radiographically over a six-month period. The study's findings promise to shed light on the potential of Galibone+ as a promising adjunct in enhancing bone regeneration following dental extractions, thereby advancing oral surgical practices and patient outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date September 2, 2025
Est. primary completion date June 2, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Participants must be of legal age. - Participants must provide informed consent for participation in the study. - Participants must require extraction of both impacted mandibular third molars. - Both impacted molars must exhibit a similar level of complexity for extraction. - Participants must have no history of infection in the impacted molars prior to extraction. - Participants must not have any contraindications to undergoing oral surgical procedures (ASA I/II classification). Exclusion Criteria: - Participants with severe mental disorders that may impair their ability to provide informed consent or follow study instructions. - Participants currently receiving medications contraindicated for dental extractions. - Participants under the age of legal consent. - Participants who have undergone head and neck radiotherapy within the past 18 months.

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
Biphasic bioceramic of tricalcium phosphate and hydroxyapatite with simvastatin
The intervention description for Galibone+ in the study involves the application of this substance to promote bone regeneration following the extraction of impacted mandibular third molars. Galibone is indicated to treat segmental and cavity bone loss, aesthetic repairs and bone augmentations (such as inlay or onlay grafts); to fill dental alveolar bone; for the placement of dental implants; for the stabilization of osteotomies and prostheses in dentistry.
Other:
Bovine Hydroxyapatite
The intervention description for Bio-Oss in the study involves the application of this standard material to promote bone regeneration following the extraction of impacted mandibular third molars. Bio-Oss is a commonly used xenograft material known for its osteoconductive properties.

Locations

Country Name City State
Spain Faculty of Dentistry University of Murcia Murcia
Spain Faculty of Dentistry of Universidade de Santiago de Compostela Santiago De Compostela A Coruña

Sponsors (2)

Lead Sponsor Collaborator
Mario Pérez Sayáns Universidad de Murcia

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Bone Regeneration_Reduction in radiolucent volume This outcome measure involves assessing the degree of bone regeneration in the extraction socket following the extraction of impacted mandibular third molars. It will be evaluated through radiological imaging using CBCT scans at specified time points, including immediately post-extraction, at one month, three months, and six months post-extraction.
Reduction in radiolucent volume within the extraction socket, indicating new bone formation (Hounsfield unit (HU)).
High values mean more radiopacity and better regeneration.
A) Immediately after extraction B) 1 month. C) 3 months. D) 6 months
Primary Bone Regeneration_bone volume This outcome measure involves assessing the degree of bone regeneration in the extraction socket following the extraction of impacted mandibular third molars. It will be evaluated through radiological imaging using CBCT scans at specified time points, including immediately post-extraction, at one month, three months, and six months post-extraction.
Evaluation of bone volume within the extraction site over time (mm3). The increase in bone volume means better regeneration.
A) Immediately after extraction B) 1 month. C) 3 months. D) 6 months
Primary Bone Regeneration_bone density This outcome measure involves assessing the degree of bone regeneration in the extraction socket following the extraction of impacted mandibular third molars. It will be evaluated through radiological imaging using CBCT scans at specified time points, including immediately post-extraction, at one month, three months, and six months post-extraction.
Changes in bone density within the regenerated bone tissue (Hounsfield unit (HU)) High values mean more radiopacity and better regeneration.
A) Immediately after extraction B) 1 month. C) 3 months. D) 6 months
Primary Bone Regeneration_Fractal dimension This outcome measure involves assessing the degree of bone regeneration in the extraction socket following the extraction of impacted mandibular third molars. It will be evaluated through radiological imaging using CBCT scans at specified time points, including immediately post-extraction, at one month, three months, and six months post-extraction.
Evaluation of bone morphology within the extraction site over time analyzing the fractal dimension (FD) FD can vary between 1 and 2, with 1 being a very simple fractal dimension (such as a straight line) and 2 being a more complex fractal dimension (such as a completely irregular surface).
A) Immediately after extraction B) 1 month. C) 3 months. D) 6 months
Secondary Pain levels through visual analog scale Assessment of pain experienced by participants using a visual analog scale (VAS) at various time points post-extraction. It comprehends values between 0-10, where 10 is the worst situation. 24 hours, 48 hours, 72 hours, and 7 days
Secondary Clinical Inflammation evaluating by presence/absence Evaluation of postoperative inflammation around the extraction site using clinical examination and assessment tools (presence/absence).
The presence of inflammation means the worst prognosis.
24 hours, 48 hours, 72 hours, and 7 days
Secondary Healing measured by healing index The healing progress will be assessed using the Healing Index (HI) developed by Hamzani & Chaushu (2018) and Landry (1988). The HI score ranges from 0 to 5, where 0 indicates poor healing and 5 indicates excellent healing.
To ensure consistency and reliability in the assessment of healing, two independent researchers will evaluate the healing progress for all participants. The level of agreement between the researchers will be assessed using Cohen's Kappa index (Mandrekar, 2011). A Cohen's Kappa index value of 0.91 was achieved for the assessment of inflammation level, indicating a high degree of agreement. Similarly, agreement levels exceeding 0.90 were obtained across all HI levels, demonstrating a high level of concordance in the assessment of healing progress.
24 hours, 48 hours, 72 hours, and 7 days
Secondary Post-surgical complications evaluated by presence or absense Monitoring and recording of any complications following the extraction procedure, such as alveolitis, trismus, infection, and hematoma (presence/absence).
The presence of complications is related to a worse prognosis.
24 hours, 48 hours, 72 hours, and 7 days
Secondary Oral Health-related Quality of Life measured by OHIP-14 test Assessment of the impact of treatment on patients' quality of life using validated instruments (OHIP-14).
Lower scores: They indicate that the person experiences less impact of oral health problems on their quality of life. That is, they have fewer problems or feel less the impact of these problems in their daily lives.
Intermediate scores: Suggest a moderate impact of oral health problems on quality of life. The person may experience some difficulties or discomfort related to their oral health, but they do not necessarily significantly affect their daily functioning.
Higher scores: Indicate a significant impact of oral health problems on quality of life. The person may experience a wide range of problems that affect their general well-being, including pain, eating difficulties, sleep problems, etc.
24 hours, 48 hours, 72 hours, and 7 days
See also
  Status Clinical Trial Phase
Completed NCT04043286 - The Effects of Dis/Reconnection of Implant Abutments on Peri-implant Bone Levels N/A
Recruiting NCT03046147 - The Effect of Roux-en-Y Gastric Bypass on Bone Turnover N/A
Completed NCT01292395 - Effects of Dietary Protein on Musculoskeletal Health During Calorie Deficiency N/A
Completed NCT00485953 - Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy Phase 4
Completed NCT00674453 - The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation Phase 2
Completed NCT00181584 - Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer Phase 2
Withdrawn NCT04380155 - Cycling Duration and Bone Markers in in Active Young Adults N/A
Active, not recruiting NCT04779216 - Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa Phase 3
Completed NCT05371418 - Comparative Clinical and Radiographical Evaluation of Treatment of Angular Bone Defect Related to Over Erupted Tooth Using GTR Followed by Orthodontic Intrusion Versus Orthodontic Intrusion Followed by GTR N/A
Not yet recruiting NCT04345250 - Bone Response to Exercise and Energy Restriction in Young Adults N/A
Active, not recruiting NCT05301400 - Marginal Bone Loss in Single Implant Restaurations With Different Methods N/A
Active, not recruiting NCT05405894 - Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
Recruiting NCT04983758 - 20-year Implant Survival in Periodontally Healthy and Compromised Patients
Recruiting NCT04713774 - Bone Density and Vascular Calcifications Evolution After Renal Transplant
Completed NCT04279392 - Healthy Body, Healthy Bones After Bariatric Surgery Trial Phase 1/Phase 2
Completed NCT04332679 - Non-resorbable Membranes Versus Titanium Meshes and Resorbable Membranes N/A
Completed NCT05721014 - Effects of OsteoStrong vs. Individually Adapted and Combined Training on Bone Health N/A
Recruiting NCT04883502 - Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs
Not yet recruiting NCT05066815 - Evaluation of Crestal Bone Loss Around Short Dental Implants As Affected By Two Suprastructure Materials N/A
Completed NCT03292146 - Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study Phase 3